Who owns ACRIVON THERAPEUTICS INC?
- Ticker: ACRV
- CUSIP Number: 004890109
Tip: Access positions for across all investors
Analyze quarterly positions in Acrivon Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Acrivon Therapeutics stock
Who bought or sold ACRIVON THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
RA Capital Management | 4.8M | $24M | 0% | Dec 2023 |
|
Perceptive Advisors | 3.0M | $15M | 0% | Dec 2023 |
|
Citadel Advisors | 1.6M | $8.1M | 0% | Dec 2023 |
|
Wellington Management Company | 888k | $4.4M | 0% | Dec 2023 |
|
Marshall Wace | 598k | $2.9M | 0% | Dec 2023 |
|
Vanguard Group | 476k | $2.3M | 2% | Dec 2023 |
|
NEA Management Company | 430k | $1.3M | 0% | Dec 2023 |
|
Federated Investors | 226k | $1.1M | 0% | Dec 2023 |
|
DAFNA Capital Management | 131k | $646k | 71% | Dec 2023 |
|
Charles Schwab Investment Management | 69k | $337k | 1% | Dec 2023 |
|
Exchange Traded Concepts | 56k | $402k | 323% | Mar 2024 |
|
Jacobs Levy Equity Management | 46k | $227k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 33k | $164k | 25% | Dec 2023 |
|
D. E. Shaw & Co | 32k | $157k | -32% | Dec 2023 |
|
Barclays | 25k | $121k | 74% | Dec 2023 |
|
Bank of New York Mellon | 24k | $175k | -2% | Mar 2024 |
|
AAFCPAs Wealth Management | 11k | $53k | 0% | Dec 2023 |
|
Raymond James & Associates | 10k | $73k | 100% | Mar 2024 |
|
Bank of America Corporation | 10k | $50k | 8% | Dec 2023 |
|
Rhumbline Advisers | 9.3k | $46k | -2% | Dec 2023 |
|
American International | 4.3k | $21k | 0% | Dec 2023 |
|
Wells Fargo & Company | 2.7k | $13k | 25% | Dec 2023 |
|
Royal Bank of Canada | 2.5k | $12k | 59% | Dec 2023 |
|
New York State Common Retirement Fund | 2.3k | $11k | -1% | Dec 2023 |
|
Citigroup | 2.0k | $10k | 790% | Dec 2023 |
|
Legal & General Group | 839.00 | $4.1k | 0% | Dec 2023 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 800.00 | $3.0k | 0% | Dec 2023 |
|
Summit Investment Advisors | 695.00 | $3.4k | 0% | Dec 2023 |
|
Amalgamated Bank | 378.00 | $3.0k | -69% | Mar 2024 |
|
Efficient Wealth Management | 88.00 | $999.996800 | 100% | Mar 2024 |
|
Capital Advisors | 48.00 | $0 | 100% | Mar 2024 |
|
CWM | 3.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Acrivon Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
UBS Group | Sep 2023 | 102.00 | $974.997600 |